Dental membranes are barrier membranes used for guided tissue regeneration (GTR) and guided bone regeneration (GBR). Their functions are to provide biosafety, biocompatibility, and appropriate mechanical properties. Constant research and development have enabled to launch of various novel membranes in the market. For dental procedures, bone grafts are used for facial trauma treatment, tooth extractions, dental implant placement, and reconstructive mouth, face, and jaw surgery. At the same time, bone graft substitutes are made from natural or synthetic materials that contain only mineralized bone matrix with no viable cells. The US dental membrane and bone graft substitute market is driven by a few key driving factors, such as the increasing burden of periodontal diseases and oral cancer and an increase in demand for dental cosmetic procedures. However, the market growth is hindered by limitations and misconceptions associated with of reimbursement policies.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
US Dental Membrane and Bone Graft Substitute Market: Strategic Insights
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 6,824.56 Million |
| Market Size by 2028 | US$ 12,769.00 Million |
| Global CAGR (2023 - 2028) | 11.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | United State
|
| Market leaders and key company profiles |
The US dental membrane and bone graft substitute market in the United States is growing due to increasing incidences of periodontal diseases and oral cancer, and growing demand of cosmetic dentistry in the country. In the US, a national health interview survey has reported a high prevalence of periodontitis based on oral health assessments; the prevalence of periodontitis among adults older than 30 is estimated at ~47%, rising to 70% in those aged 65 and above. The prevalence of moderate and severe periodontitis, which is more closely associated with systemic inflammation and the immune response, is very high in adults over 65. Periodontal disease can lead to resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening & falling of the teeth. Therefore, treatment of periodontal disease focuses on eliminating the source of infection, stimulating factors, and pays attention to repairing periodontal tissue defects and restoring normal morphology & function. Bone grafting is done for repairing periodontal defects by grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the US dental membrane and bone graft market. Also, according to the American Academy of Cosmetic Dentistry, the US alone spent ~US$ 2.75 billion annually on cosmetic dentistry in 2021. According to the Cosmetic Dentistry: State of the Industry Report, an average patient spent US$ 4,336 on cosmetic dentistry in 2019 in the US. Therefore, an upsurge in demand for cosmetic dentistry is favoring the dental membrane and bone graft substitute market.
The US dental membrane and bone graft substitute market majorly consists of players such as Dentsply Sirona Inc, Dentium Co Ltd, Geistlich Pharma AG, ZimVie Inc, Keystone Dental Inc, Straumann Holding AG, Medtronic Plc, BioHorizons Inc, MEDOSIS, and LifeNet Health Inc. among others.
Dental membranes are barrier membranes used for two procedures: guided tissue regeneration (GTR) and guided bone regeneration (GBR). The functions of the membranes are to provide biosafety, biocompatibility, and appropriate mechanical properties. Also, a dental membrane needs to be bioactive to promote tissue regeneration. Various commercially available membranes are on the market, and constant research and development for novel membranes are conducted to introduce new ones. For dental procedures, bone grafts are used for facial trauma treatment, tooth extractions, dental implant placement, and reconstructive mouth, face, and jaw surgery. Bone graft substitutes are natural or synthetic materials often containing only mineralized bone matrix with no viable cells.
Key factors such as increasing burden of periodontal diseases and oral cancer and increase in demand for dental cosmetic procedures are expected to boost the market growth for the US dental membrane and bone graft substitute over the years.
The grafting procedures segment dominated the US dental membrane and bone graft substitute market and held the largest revenue share of 85.65% in 2022.
The grafting procedures segment dominated the US dental membrane and bone graft substitute market and held the largest revenue share of 85.65% in 2022.
The dental clinics segment dominated the US dental membrane and bone graft substitute market and accounted for the largest revenue share of 61.63% in 2022.